Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Total Non-Current Liabilities (2019 - 2025)

Historic Total Non-Current Liabilities for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $72.3 million.

  • Biodesix's Total Non-Current Liabilities rose 1674.5% to $72.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.3 million, marking a year-over-year increase of 1674.5%. This contributed to the annual value of $62.1 million for FY2024, which is 155.65% up from last year.
  • As of Q3 2025, Biodesix's Total Non-Current Liabilities stood at $72.3 million, which was up 1674.5% from $71.4 million recorded in Q2 2025.
  • Over the past 5 years, Biodesix's Total Non-Current Liabilities peaked at $72.3 million during Q3 2025, and registered a low of $24.1 million during Q1 2022.
  • In the last 5 years, Biodesix's Total Non-Current Liabilities had a median value of $56.7 million in 2023 and averaged $53.3 million.
  • Per our database at Business Quant, Biodesix's Total Non-Current Liabilities plummeted by 6176.86% in 2022 and then surged by 12505.09% in 2023.
  • Biodesix's Total Non-Current Liabilities (Quarter) stood at $27.4 million in 2021, then skyrocketed by 80.45% to $49.5 million in 2022, then increased by 23.53% to $61.1 million in 2023, then grew by 1.56% to $62.1 million in 2024, then grew by 16.5% to $72.3 million in 2025.
  • Its Total Non-Current Liabilities was $72.3 million in Q3 2025, compared to $71.4 million in Q2 2025 and $61.9 million in Q1 2025.